Eye drop showdown: new treatment takes on standard for dry eyes
NCT ID NCT05865457
Summary
This study aims to see if a new eye drop called BUFY02 works as well as an existing treatment called TRB02 for people with dry eye disease. About 80 participants will use one of the two treatments daily for three months and attend several clinic visits for check-ups and questionnaires. The main goal is to compare how well each treatment improves both the physical signs and the uncomfortable symptoms of dry eyes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHRU Brest
RECRUITINGBrest, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Nice
RECRUITINGNice, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpital Bicêtre
RECRUITINGLe Kremlin-Bicêtre, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Medical University Graz
RECRUITINGGraz, Austria
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
VIROS
RECRUITINGVienna, Austria
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.